11–20 of 101 posts
As much as I'd love to see ridiculous parent laws in medicine get under control, I have very little confidence that Lina Kahn would accomplish anything. She doesn't have a great track record. You really need someone with a good background in patent law specifically for pharmaceuticals to take this on
As much as I'd love to see ridiculous parent laws in medicine get under control, I have very little confidence that Lina Kahn would accomplish anything. She doesn't have a great track record. You really need someone with a good background in patent law specifically for pharmaceuticals to take this on
As much as I'd love to see ridiculous parent laws in medicine get under control, I have very little confidence that Lina Kahn would accomplish anything. She doesn't have a great track record. You really need someone with a good background in patent law specifically for pharmaceuticals to take this on
I followed Lina Kahn (FTC chair) on Twitter before Biden appointed her, and I was kind of blown away that it happened. She had a very clear philosophical opposition to a lot of the way things are done in this country. And I mean, I followed her because I agreed! But my preferences are not mainstream. Amazing to see her slinging rocks at giants from this position.
Earlier quoted context omitted.
Maybe it was her surname. This "hipster antitrust" approach is a nice smoke screen big pharma needs. India and other countries already make generics, there is no need to wait several years for US manufacturers. FTC is just a road block that prevents cheap medical imports.
Is it really though. Even with the current level of regulation we have more than enough scandals with, say, artificial tears that blinded people who used them.
As much as I'd love to see ridiculous parent laws in medicine get under control, I have very little confidence that Lina Kahn would accomplish anything. She doesn't have a great track record. You really need someone with a good background in patent law specifically for pharmaceuticals to take this on
[deleted]
The history of the FDA is pretty interesting and disappointing to say the least. Especially with the supplement craze.
As much as I'd love to see ridiculous parent laws in medicine get under control, I have very little confidence that Lina Kahn would accomplish anything. She doesn't have a great track record. You really need someone with a good background in patent law specifically for pharmaceuticals to take this on
Definitely, experience matters. However, I am used to an FTC that turns a blind eye on these Pharma antics. So, as long as FTC takes these kind of cases on, I am all for it. Even the price of generics are way out of line when compared to the generics you get outside of US. Similarly, a lot of Mergers have resulted in fewer competition in the market, leading to rampant price inflation. Federal institutes like FTC need…
I followed Lina Kahn (FTC chair) on Twitter before Biden appointed her, and I was kind of blown away that it happened. She had a very clear philosophical opposition to a lot of the way things are done in this country. And I mean, I followed her because I agreed! But my preferences are not mainstream. Amazing to see her slinging rocks at giants from this position.
Khan's utter failure to execute on her goals has imo set back the anti-trust movement in this country heavily. Now every time anti trust gets brought up people think about how the government lost 5 cases in a row and consider it a waste.
"An Orange Book listing shows "approved prescription drugs, related patent and exclusivity information, and therapeutic equivalence evaluations, along with other information."
https://www.fda.gov/drugs/news-events-human-drugs/our-perspe...
So a pharma company can insert a listing saying that, for a bogus example, "Vioxx has no approved generics, because all substitutes are under patent or patent pending." when that is untrue.
This seems clearly illegal and abusive.
From the headline, I thought Kahn was saying that filing a trivial patent "improving" Vioxx would be illegal. But that's not it.